Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19 A Systematic Review and Meta-analysis
Research
[키워드] 95% CI
ACEi
ACEIs
adjusted
adjusted analyses
Adjusted analysis
Admission
AEs
angiotensin receptor blocker
angiotensin-converting enzyme inhibitor
ARB
ARBs
article
articles
assisted ventilation
association
assumed
benefit
Case series
case-control studies
clinical
Clinical outcome
clinical outcomes
Clinicians
Cohort studies
Complication
contrary
coronavirus disease
covariates
COVID-19
cross-sectional
database
decrease
defined
diagnosed
duplicates
eligible
evaluated
exacerbate
extraction
finding
Future
higher risk
hypertension
Importance
increased risk
indicated
intensive care
Laboratory
measure
Meta-analysis
Mortality
multiple comorbidities
objective
Odds ratio
outcome
Patient
patients with COVID-19
Point
Protective
radiological
random-effects model
randomized clinical trial
receive
receiving
recommendation
reductions in
Relevance
Result
review
risk
risk of death
screened
searched
Selection
severe adverse event
severe AE
significant decrease
significantly lower
Source
Study design
subgroup analysis
subgroup of patient
synthesis
System
systematic review
total patient
total patients
Treatment
was used
were assessed
with COVID-19
[DOI] 10.1001/jamanetworkopen.2021.3594 PMC 바로가기 [Article Type] Research
[DOI] 10.1001/jamanetworkopen.2021.3594 PMC 바로가기 [Article Type] Research